The Clinical Characteristics and Antimicrobial Resistance of Staphylococcus aureus Isolated from Patients with Staphylococcal Scalded Skin Syndrome (SSSS) in Southwestern China

Yidan Wu,Hengfeng Wu,Man Wu,Wanchen Wei,Yuying Wei,Tiantian Li,Cunwei Cao,Zhijian Yao
DOI: https://doi.org/10.3390/antibiotics13060516
2024-06-01
Antibiotics
Abstract:Staphylococcal scalded skin syndrome (SSSS) is a rare, toxin-mediated, desquamating bacterial infectious dermatosis. So far, data from Southwestern China is scarce. This study aimed to investigate the clinical characteristics of SSSS patients in our hospital, the relative proportion of methicillin-resistant Staphylococcus aureus (MRSA) in skin and soft tissue secretions, and the drug sensitivity of S. aureus to better assist dermatologists in the diagnosis and treatment of SSSS. We reviewed the demographic characteristics, clinical manifestations, treatment regimens, therapeutic efficacy, laboratory test results, drug sensitivity, and outcome data of 79 SSSS patients from January 2012 to December 2021. Statistical analysis was performed using t tests and chi-square tests. Among the 79 SSSS patients, MRSA was detected in 35 (44.3%) isolates: 34 community-acquired (CA)-MRSA (97.1%) and 1 hospital-acquired (HA)-MRSA. The SSSS incidence increased annually from 2012 to 2014 and then decreased gradually after peaking in 2015. All the isolates were sensitive to vancomycin, tigecycline, linezolid, moxifloxacin, levofloxacin, and ciprofloxacin; were completely resistant to penicillin; and had low sensitivity to clindamycin and erythromycin. Interestingly, the sensitivity of MRSA to tetracycline increased annually after 2015. The resistance rates to common drugs previously used to treat SSSS increased. These findings may accelerate diagnosis and improve empirical antibiotic use, suggesting that clinicians should prescribe drugs according to antimicrobial susceptibility.
pharmacology & pharmacy,infectious diseases
What problem does this paper attempt to address?
The main aim of this paper is to study the clinical characteristics and antibiotic resistance of Staphylococcal Scalded Skin Syndrome (SSSS) caused by Staphylococcus aureus in the southwestern region of China, with a particular focus on Methicillin-resistant Staphylococcus aureus (MRSA). Specifically, the research objectives include: 1. **Investigate the clinical characteristics of SSSS patients**: A retrospective analysis was conducted on the demographic characteristics, clinical manifestations, treatment regimens, and outcomes of 79 SSSS patients from 2012 to 2021. 2. **Determine the proportion of MRSA in skin and soft tissue secretions**: The study found that among these 79 SSSS patients, 44.3% of the cases were caused by MRSA, with the vast majority being community-acquired MRSA (CA-MRSA), and only 1 case being hospital-acquired MRSA (HA-MRSA). 3. **Evaluate the sensitivity of Staphylococcus aureus to different antibiotics**: All isolates were sensitive to antibiotics such as vancomycin, tigecycline, linezolid, moxifloxacin, levofloxacin, and ciprofloxacin; however, they were completely resistant to penicillin and had low sensitivity to clindamycin and erythromycin. Notably, since 2015, the sensitivity of MRSA to tetracycline has increased year by year. Through these studies, the authors hope to provide clinicians with important information regarding the diagnosis and treatment of SSSS, especially in the face of MRSA infections, to better guide the selection and use of antibiotics. Additionally, the research reveals trends in the incidence of SSSS and changes in the antibiotic resistance of Staphylococcus aureus in recent years, which is significant for formulating effective preventive measures in the future.